RECENT FUNDING ROUNDS
|47 Labs||Healthcare through neuro-simulation.||Pre Seed|
|ValenzaBio Inc||antibody for inflammatory eye disease||Series A||USD 70,000,000|
|Blossomhill Therapeutics Inc||Biotechnology company focused on oncology and autoimmune disorders.||Series A||USD 71,000,000|
|Maridose LLC||Biotech - Cannabis R&D. We are a US DEA licensed manufacturer of Schedule 1 drugs.||Pre Seed||USD 150,000|
|Perfect Day Inc||Series C||USD 140,000,000|
|Quell Therapeutics Ltd||Developer of engineered T regulatory cell therapies.||Series A||GBP 35,000,000|
|Aquaro Histology Inc||Provider of solutions that improve workflow efficiency, section quality, and consistency in the histology laboratory.||Series A||USD 9,810,879|
|3SBio Inc||IPO||HKD 5,510,000,000|
|Solazyme Inc||Renewable oil and bioproducts company and the leader in algal biotechnology||Series D|
|Solazyme Inc||Renewable oil and bioproducts company and the leader in algal biotechnology||Grant|
MOST ACTIVE INVESTORS
|Braemar Energy Ventures LLC||US||2|
|Chevron Technology Ventures LLC||US||1|
|CTTV Investments LLC||US||1|
|Harris & Harris Group Inc||US||1|
|Lightspeed Management Co LLC||US||1|
|Morgan Stanley & Co Inc||US||1|
|The Roda Group||US||1|
|San-Ei Gen FFI Inc||GB||1|
|VantagePoint Capital Partners||US||1|
Biotechnology company focused on oncology and autoimmune disorders.
Provider of solutions that improve workflow efficiency, section quality, and consistency in the histology laboratory.
Biotech - Cannabis R&D. We are a US DEA licensed manufacturer of Schedule 1 drugs.
Renewable oil and bioproducts company and the leader in algal biotechnology
Elevate Ventures nurtures and develops emerging and existing high-potential businesses into high-performing, Indiana-based companies.
Biotechnology company focused on developing new products to eliminate bacterial infections.
Developer of engineered T regulatory cell therapies.
Biotechnology company developing a new class of therapies for metabolic diseases and disorders.
antibody for inflammatory eye disease